Partner Investment Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$431K Sell
9,484
-19,393
-67% -$917K 3.09% 16
2019
Q3
$1.32M Buy
28,877
+10,718
+59% +$602K 2.26% 14
2019
Q2
$1.06M Sell
18,159
-22,446
-55% -$1.16M 1.13% 34
2019
Q1
$1.82M Buy
40,605
+1,197
+3% +$54.9K 2.1% 15
2018
Q4
$1.53M Buy
39,408
+4,728
+14% +$186K 1.92% 19
2018
Q3
$1.6M Buy
34,680
+17,018
+96% +$690K 1.22% 30
2018
Q2
$770K Buy
+17,662
New +$759K 0.62% 64

Other funds holding ARNA

Partner Investment Management's ARNA Position: Q4 2019 in Review

Partner Investment Management reduced its Arena Pharmaceuticals Inc (ARNA) stake by 67% in Q4 2019, selling an estimated $917K and leaving 9,484 shares worth $431K. The position accounts for 3.09% of the portfolio, ranked #16.

Partner Investment Management first reported a position in ARNA in Q2 2018 and has held it in 7 quarters since. The position peaked at $1.82M in Q1 2019. 226 funds tracked by Wall St. Rank hold ARNA as of Q4 2019.

  • Partner Investment Management held 9,484 shares of Arena Pharmaceuticals Inc worth $431K as of Q4 2019.
  • Partner Investment Management sold 19,393 Arena Pharmaceuticals Inc shares in Q4 2019, an estimated $917K.
  • Arena Pharmaceuticals Inc made up 3.09% of Partner Investment Management's portfolio in Q4 2019, its #16 holding.
  • Partner Investment Management first reported a position in Arena Pharmaceuticals Inc in Q2 2018 and has held it in 7 quarters since.
  • Partner Investment Management's Arena Pharmaceuticals Inc position peaked at $1.82M in Q1 2019.
  • 226 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2019.

Based on Partner Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.